Nektar Therapeutics Stock News

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Revance Therapeutics ( RVNC – Research Report ), with a price target of $35.00 . The company’s shares close

Medicenna's IL-2 Superkine, MDNA19, released recent data from non-human primate study suggesting best-in-class features. The small pilot study in monkeys showed

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Sarepta Therapeutics (SRPT), with a price target of $183.00. The

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Sarepta Therapeutics ( SRPT – Research Report ), with a price target of $183.00 . The company’s shares clos

Upgrades Cowen & Co. changed the rating for Cerner Corp (NASDAQ: CERN) from Market Perform to Outperform. Cerner earned $0.75 in the fourth quarter, compared...

Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.

BioSig Technologies (NASDAQ:BSGM) initiated with Buy rating and $9 (75% upside) price target at Roth Capital.Amgen (NASDAQ:AMGN) upgraded to Outperform with a $255 (29% upside) price target at Raymond

Goldman Sachs analyst Paul Choi upgraded Nektar Therapeutics to Neutral from Sell with a price target of $20, up from $18.

Nektar upgraded to Neutral from Sell at Goldman Sachs Goldman Sachs NKTR

Nektar Therapeutics (NASDAQ:NKTR) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Monday, BidAskClub reports

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa

Wir sitzen zu Hause, haben Zeit und sehen plötzlich, dass sich vor unserem Fenster ganz viel Natur abspielt. Wir erklären Ihnen, was da gerade passiert.